Let the Arms Race End: Opening the Door to Flexible Drug Marketing Regulation through an IP Justification
Posted on May 25, 2012Written By: Sally Wang Edited By: Charlie Stiernberg Editorial Policy Introduction: Drug marketing faces the problem of an arms race — competitors attempt to out-compete each other by boosting their marketing efforts, at great expense, only to find that the baseline level of marketing needed to maintain the status quo has increased accordingly. These inefficiencies are costly and often harmful to the...
Continue reading
Continue reading